Ovalbumin (OVA) genetically fused to protein sigma 1 (pσ1) results in tolerance to both OVA and pσ1. Pσ1 binds in a multi-step fashion, involving both protein- and carbohydrate-based receptors. To assess the relative pσ1 components responsible for inducing tolerance and the importance of its sialic binding domain (SABD) for immunization, modified OVA-pσ1, termed OVA-pσ1(short), was deleted of its SABD, but with its M cell targeting moiety intact, and was found to be immunostimulatory and enhanced CD4+ and CD8+ T cell proliferation. When used to nasally immunize mice given with and without cholera toxin (CT) adjuvant, elevated SIgA and serum IgG responses were induced, and OVA-pσ1(s) was more efficient for immunization than native OVA+CT. The immune antibodies (Abs) were derived from elevated Ab-forming cells in the upper respiratory tissues and submaxillary glands and were supported by mixed Th cell responses. Thus, these studies show that pσ1(s) can be fused to vaccines to effectively elicit improved SIgA responses. © 2012 Zlotkowska et al.
CITATION STYLE
Zlotkowska, D., Maddaloni, M., Riccardi, C., Walters, N., Holderness, K., Callis, G., … Pascual, D. W. (2012). Loss of sialic acid binding domain redirects protein σ1 to enhance M cell-directed vaccination. PLoS ONE, 7(4). https://doi.org/10.1371/journal.pone.0036182
Mendeley helps you to discover research relevant for your work.